Leerink Partnrs Issues Pessimistic Estimate for DGX Earnings
Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest Diagnostics in a research report issued to clients and investors on Friday, April 4th. Leerink Partnrs analyst M. Cherny now expects that the medical research company will earn $2.58 […]
Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest Diagnostics in a research report issued to clients and investors on Friday, April 4th. Leerink Partnrs analyst M. Cherny now expects that the medical research company will earn $2.58 […]
